infliximab 100 MG Injection [Remicade]
- RxCUI
- 213361
- RxNorm name
- infliximab 100 MG Injection [Remicade]
- Display name
- infliximab 100 MG Injection [Remicade]
- Full name
- infliximab 100 MG Injection [Remicade]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:11
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103772 | Remicade | infliximab | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| REMICADE | INFLIXIMAB | Janssen Biotech, Inc. | a0a046c1-056d-45a9-bfd9-13b47c24f257 | 2025-06-03 | Boxed warning, Warnings, Adverse reactions | 213361 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a0a046c1-056d-45a9-bfd9-13b47c24f257 | Remicade 100 MG Injection [PSN] · infliximab 100 MG Injection [Remicade] [SBD] · Remicade 100 MG Injection [SY] · Remicade 100 MG per 10 ML Injection [SY] | 4 | 37 | These highlights do not include all the information needed to use REMICADE safely and effectively. See full prescribing information for REMICADE. REMICADE ® (infliximab) for injection, for intravenous use Initial U.S. Approval: 1998 | 20250603 |